Therefore, miR-18a-5p might negatively regulate the TGF-β signaling-mediated EMT pathway in PMCs and a pulmonary fibrosis animal model by targeting TGF-βRII gene expression. This evidence concerns the gene TGFB1 and pulmonary fibrosis.